NIKKEI 225
38,460.08 +907.92 (+2.42%) HANG SENG
17,201.27 +372.34 (+2.21%) CRUDE OIL
82.55 -0.81 (-0.97%) GOLD FUTURES
2,337.70 -4.40 (-0.19%) DOW
38,499.88 -3.81 (-0.01%) Bitcoin GBP
52,223.94 -1,413.85 (-2.64%)
Pfizer Inc. (PFE)
| Previous close | 26.32 |
| Open | 26.25 |
| Bid | 26.20 x 1800 |
| Ask | 26.21 x 4000 |
| Day's range | 26.04 - 26.34 |
| 52-week range | 25.23 - 40.37 |
| Volume | |
| Avg. volume | 42,576,651 |
| Market cap | 148.557B |
| Beta (5Y monthly) | 0.57 |
| PE ratio (TTM) | 70.91 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 1.68 (6.38%) |
| Ex-dividend date | 25 Jan 2024 |
| 1y target est | N/A |
- Zacks
Will Healthcare ETFs Lose Momentum as Q1 Earnings Unfold?
While the healthcare sector is expected to benefit from cutting-edge medicines, new drug approvals, technological advancements, and deal activities, it is expected to witness a modest earnings decline of 5.6% in the first quarter.
- Zacks
Analysts Estimate Pfizer (PFE) to Report a Decline in Earnings: What to Look Out for
Pfizer (PFE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Reuters
Pfizer vs Moderna battle over COVID vaccine patents begins in UK
Pfizer and BioNTech asked a London court to revoke rival Moderna's patents over technology key to the development of vaccines for COVID-19, as the latest leg of a global legal battle began on Tuesday. Pfizer and its German partner BioNTech sued Moderna at London's High Court in September 2022, seeking to revoke patents held by Moderna, which hit back days later alleging its patents had been infringed. Moderna says Pfizer and BioNTech copied mRNA advances it had pioneered and patented well before the COVID-19 pandemic began in late 2019.
